Cava Group, Inc. <CAVA.N>: Mizuho Cuts Target Price to $70 From $85
CAVA•Related News
Nebius beats quarterly revenue estimates as AI demand fuels growth
NBIS•
Local Bounti Q2 revenue rises on higher production and sales
LOCL•
Nebius Group rises, posts upbeat Q2 revenue
NBIS•
Capstone Therapeutics restates Q3 2025 weighted-average shares, lifts loss per share to USD 0.34
CAPS•
CoreWeave, Inc. <CRWV.O>: Truist Securities raises target price to $155 from $126
CRWV•